US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 276 actively recruiting studies with Virginia sites out of 276 registered in total. The busiest research areas in Virginia are Breast Cancer, Advanced Solid Tumor, Colorectal Cancer. Leading sponsors running trials in the state include Virginia Commonwealth University, University of Virginia, National Cancer Institute (NCI). By stage, Virginia trials break down as Phase 1 (75), Phase 2 (82), Phase 3 (85), Phase 4 (13).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
276
Recruiting Now
276
← Back to US Map
Top Conditions in Virginia
Breast Cancer (12)Advanced Solid Tumor (9)Colorectal Cancer (8)Solid Tumor (8)Prostate Cancer (8)Advanced Solid Tumors (7)Solid Tumors (6)Cancer (5)Ovarian Cancer (5)Obesity (5)Endometrial Cancer (4)Non-Small Cell Lung Cancer (4)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 276 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 276. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT05660525 N/A
Recruiting
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rura...
Condition
Smoking Cessation
Enrollment
768 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07223840 Phase 2
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid R...
Condition
Smoking
Enrollment
222 pts
Location
United States, China, Japan
Sponsor
Eli Lilly and Company
View Trial →
NCT07723963 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment ...
Condition
Juvenile Myoclonic Epilepsy
Enrollment
260 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
View Trial →
NCT06965504 N/A
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure ...
Condition
Heart Failure
Enrollment
250 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT05475925 Phase 1, Phase 2
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotox...
Condition
LGLL - Large Granular Lymphocytic Leukemia
Enrollment
200 pts
Location
United States, Australia, France
Sponsor
Dren Bio
View Trial →
NCT07475247 N/A
Recruiting
A Hospital-based Intervention for Youth Injured Through Violence
Condition
Violence
Enrollment
360 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT06425926 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Condition
Melanoma Stage IV
Enrollment
117 pts
Location
United States
Sponsor
Georgiamune Inc
View Trial →
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT06270316 Phase 1, Phase 2
Recruiting
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Diseas...
Condition
Fabry Disease
Enrollment
20 pts
Location
United States
Sponsor
UniQure Biopharma B.V.
View Trial →
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06440005 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in P...
Condition
Cancer
Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
View Trial →
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada, South Korea
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06682494 N/A
Recruiting
Enhancing Oral Cancer Awareness
Condition
Oral Cancer
Enrollment
60 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT04915183 Phase 2
Recruiting
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Hea...
Condition
Hearing Loss
Enrollment
224 pts
Location
United States
Sponsor
National Institute on Deafness
View Trial →
NCT04904757 N/A
Recruiting
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
Condition
Mammographic Breast Density
Enrollment
210 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT06994806 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in C...
Condition
Solid Tumor Malignancies
Enrollment
84 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT05761223 Phase 1, Phase 2
Recruiting
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and ...
Condition
Advanced Solid Tumor
Enrollment
151 pts
Location
United States
Sponsor
1ST Biotherapeutics, Inc.
View Trial →
NCT07277946 N/A
Recruiting
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Saf...
Condition
Hernia
Enrollment
240 pts
Location
United States
Sponsor
Tissium
View Trial →
Page 4 of 12 — 276 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology